Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers.

Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers.

<h4>Background</h4>Today, dementias are diagnosed late in the course of disease. Future treatments have to start earlier in the disease process to avoid disability requiring new diagnostic tools. The objective of this study is to develop a new method for the differential diagnosis and id...

Full description

Bibliographic Details
Main Authors: Holger Jahn, Stefan Wittke, Petra Zürbig, Thomas J Raedler, Sönke Arlt, Markus Kellmann, William Mullen, Martin Eichenlaub, Harald Mischak, Klaus Wiedemann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22046305/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22046305/?tool=EBI

Similar Items